Comparing the Frequency of Osteoporosis and Osteopenia in Chronic Hepatitis B Patients with and without Tenofovir treatment

ConclusionA significant reduction in bone density was observed in patients with chronic hepatitis B receiving Tenofovir for more than 12 months in comparison with the control group. Also, the patients who had been taking Tenofovir in longer time, osteoporosis and osteopenia were more reported.
Source: Clinical Epidemiology and Global Health - Category: Epidemiology Source Type: research